ATE428406T1 - Bioadhäsive zusammensetzung - Google Patents

Bioadhäsive zusammensetzung

Info

Publication number
ATE428406T1
ATE428406T1 AT01909120T AT01909120T ATE428406T1 AT E428406 T1 ATE428406 T1 AT E428406T1 AT 01909120 T AT01909120 T AT 01909120T AT 01909120 T AT01909120 T AT 01909120T AT E428406 T1 ATE428406 T1 AT E428406T1
Authority
AT
Austria
Prior art keywords
bioadhesive composition
solid
solution
polymer mixture
polymer
Prior art date
Application number
AT01909120T
Other languages
English (en)
Inventor
Paul Foreman
Paul Richardson
John Tsai
Jean-Paul Remon
Jody Voorspoels
Dieter Ameye
Catherine Callens
Original Assignee
Nat Starch Chem Invest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Starch Chem Invest filed Critical Nat Starch Chem Invest
Application granted granted Critical
Publication of ATE428406T1 publication Critical patent/ATE428406T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246—Intercrosslinking of at least two polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers
    • C08J2300/10—Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • C08J2300/104—Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Materials For Medical Uses (AREA)
AT01909120T 2000-02-11 2001-02-08 Bioadhäsive zusammensetzung ATE428406T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/502,585 US6284235B1 (en) 2000-02-11 2000-02-11 Bioadhesive composition
PCT/US2001/004418 WO2001058430A1 (en) 2000-02-11 2001-02-08 Bioadhesive composition

Publications (1)

Publication Number Publication Date
ATE428406T1 true ATE428406T1 (de) 2009-05-15

Family

ID=23998471

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01909120T ATE428406T1 (de) 2000-02-11 2001-02-08 Bioadhäsive zusammensetzung

Country Status (6)

Country Link
US (2) US6284235B1 (de)
EP (1) EP1257258B1 (de)
AT (1) ATE428406T1 (de)
AU (1) AU2001236905A1 (de)
DE (1) DE60138362D1 (de)
WO (1) WO2001058430A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284235B1 (en) * 2000-02-11 2001-09-04 National Starch And Chemical Company Investment Holding Corporation Bioadhesive composition
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
DK1411899T3 (da) * 2001-08-01 2009-06-02 Novartis Ag Smagsmaskerende sammensætning
US7846478B2 (en) * 2002-01-31 2010-12-07 Henkel Ag & Co. Kgaa Bioadhesive composition
WO2005009368A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US8758820B2 (en) 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
DE10358748A1 (de) * 2003-12-12 2005-07-14 Lts Lohmann Therapie-Systeme Ag Darreichungsform basierend auf vernetzten hydrophilen Polymeren
AU2005219443A1 (en) * 2004-03-03 2005-09-15 Spherics, Inc. Polymeric drug delivery system for hydrophobic drugs
US20050276771A1 (en) * 2004-06-10 2005-12-15 Lewis Farsedakis Color-giving lip covering, color for lips, peelable cosmetics, and other cosmetics
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US20060045865A1 (en) * 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
DK1796747T3 (en) * 2004-08-27 2017-10-16 Antonio Lauto BIOADHASIVE MOVIE FOR TISSUE REPAIR
US20070281007A1 (en) * 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
AU2006213822B2 (en) * 2005-02-09 2011-05-26 Covidien Lp Synthetic sealants
US20070026052A1 (en) * 2005-07-28 2007-02-01 Baggett Richard W Hemostatic material
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US20070190013A1 (en) * 2006-02-13 2007-08-16 Yeli Zhang Film and film-forming compositions
WO2007127172A2 (en) * 2006-04-27 2007-11-08 The Trustees Of Columbia University In The City Of New York Layered bio-adhesive compositions and uses thereof
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
EP2197461B1 (de) 2007-10-08 2018-02-21 Aurinia Pharmaceuticals Inc. Ophthalmische zusammensetzungen mit calcineurin-hemmern oder mtor-hemmern
US9017725B2 (en) 2009-06-09 2015-04-28 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
DE102014012238A1 (de) 2014-08-21 2016-02-25 Johns Manville Europe Gmbh Binderverfestigtes, textiles Flächengebilde, Verfahren zu dessen Herstellung und dessen Verwendung
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US10588998B2 (en) 2015-08-07 2020-03-17 Xcede Technologies, Inc. Adhesive compositions and related methods
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
EP3982913A1 (de) 2019-06-14 2022-04-20 The Procter & Gamble Company Mundpflegezusammensetzungen ohne ausspülen
WO2020248232A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
BR112021024266A2 (pt) 2019-06-14 2022-01-11 Procter & Gamble Composições para tratamento bucal sem enxágue
MX2021015126A (es) 2019-06-14 2022-01-24 Procter & Gamble Composiciones para el cuidado bucal para usar y no enjuagar.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
CA2018471A1 (en) * 1989-07-28 1991-01-28 Ian W. Kellaway Mucoadhesive hydrogels delivery system
DK0500807T3 (da) * 1989-10-31 2000-02-07 Columbia Lab Inc Præparat og fremgangsmåde til befugtning af væv
EP0451433B1 (de) * 1990-04-12 1996-10-23 Janssen Pharmaceutica N.V. Zusammensetzung zur Anwendung eines Arzneimittels, bestehend aus einem Bioadhäsiven Trägerstoff mit verzögerter Freisetzung
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
WO1998022097A2 (en) * 1996-11-20 1998-05-28 Bio Advances, Llc Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
US5895804A (en) 1997-10-27 1999-04-20 National Starch And Chemical Investment Holding Corporation Thermosetting polysaccharides
AU2547900A (en) 1999-02-12 2000-08-29 Ben-Gurion University Of The Negev Research & Development Authority A biocompatible adhesive system and a bioadhesive drug delivery system with controllable release
US6284235B1 (en) * 2000-02-11 2001-09-04 National Starch And Chemical Company Investment Holding Corporation Bioadhesive composition

Also Published As

Publication number Publication date
EP1257258B1 (de) 2009-04-15
AU2001236905A1 (en) 2001-08-20
EP1257258A1 (de) 2002-11-20
DE60138362D1 (de) 2009-05-28
WO2001058430A1 (en) 2001-08-16
US6284235B1 (en) 2001-09-04
US6824792B2 (en) 2004-11-30
US20020028241A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
ATE428406T1 (de) Bioadhäsive zusammensetzung
DE60219319D1 (de) Trockene hämostatische zusammensetzungen und verfahren zu ihrer herstellung
ATE245219T1 (de) Verfahren zur herstellung von konditionierungstüchern
ATE258685T1 (de) Makromolekulare mikropartikel und verfahren zur ihrer herstellung
BR9808516A (pt) Processo para a produção de composições de gel de baixa densidade
BR9205783A (pt) Composição biodegradável, processo para produzí-la, e processo de moldá-la.
ATE270962T1 (de) Zusammensetzungen und verfahren zum selektiven vernetzen von filmen und daraus hergestellte filmgegenstande
ATE323118T1 (de) Verfahren zur herstellung von derivaten des polyarylenvinylen
DE59801854D1 (de) Verfahren zur herstellung von feinteiligen polysaccharidderivaten
DE69941954D1 (de) Oxetanderivate, oxetancopolymer, und verfahren zur herstellung von oxetanderivaten
DE69811948T2 (de) Verfahren zur unterkritischen trocknung vonlyo-gelen zur herstellung von aerogelen
AR007208A1 (es) Metodos para producir protoplastos de mandioca.
BR9814240A (pt) Processo para a produção de composições de gel de baixa densidade
CA2400300A1 (en) Method for producing shredded tobacco and production system for use therein
DE69709798D1 (de) Verfahren und doppeltzylinder-rundstrickmaschine zur herstellung von gerippten socken und dergleichen
BR9908788A (pt) Rede polimérica de poliaspartato de ligação cruzada e método para produzir a mesma
SE0004928D0 (sv) A method for the manufacturing of porous material
ATE403413T1 (de) Verfahren zur herstellung von kosmetischen zusammensetzungen
IT1314768B1 (it) Processo per la produzione di additivi antifiamma per composizionipolimeriche,e prodotti ottenuti da detto processo
FI965110A (fi) Menetelmä ja laitteisto ns. vaahtoprosessilla muodostettavan kuiturainan valmistuksessa syntyvän ja/tai tarvittavan vaahtoseoksen käsittelemiseksi
BR9800801A (pt) Composição aquosa, pó de polímero e processos para preparar o mesmo, para preparar emulsões de polímero e para modificar uma composição de cimento.
AU3115095A (en) Method for preparing co-granules, co-granules thus obtained and use thereof as a component in detergent compositions
ATE372994T1 (de) Herstellung von milchsäurederivaten und ihre anwendung
DE69811637T2 (de) Stufenweise Kondensation und dynamisches Vernetzungsverfahren zur Herstellung einer im wesentlichen weichmacherfreien Plastik-Gummi-Mischung
DE69926795D1 (de) Derivate von 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide und verfahren zur deren herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties